Premium
CALHM1 Polymorphism is not Associated with Late‐onset Alzheimer Disease
Author(s) -
Beecham Gary W.,
SchnetzBoutaud Nathalie,
Haines Jonathan L.,
PericakVance Margaret A.
Publication year - 2009
Publication title -
annals of human genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.537
H-Index - 77
eISSN - 1469-1809
pISSN - 0003-4800
DOI - 10.1111/j.1469-1809.2009.00509.x
Subject(s) - odds ratio , allele , cohort , polymorphism (computer science) , disease , alzheimer's disease , association (psychology) , genetic association , case control study , medicine , genetics , biology , gene , psychology , genotype , single nucleotide polymorphism , psychotherapist
Summary Data suggests that the P86L polymorphism (rs2986017) in the calcium homeostasis modulator 1 ( CALHM1 ) gene interferes with CALHM1 functionality, increases Aβ levels, and is associated with late‐onset Alzheimer's disease (LOAD). Previous studies have demonstrated association with P86L and LOAD in three of five case‐control cohorts, and a joint analysis of all datasets showed association with a p‐value of 2 × 10 −10 and an allele‐specific odds ratio of 1.44 (2,043 cases, 1,361 controls total). In this short communication we attempt to replicate these results in our case‐control cohort (510 cases, 524 controls). We show no association between P86L and LOAD despite having sufficient power to detect at the reported odds ratios, and briefly discuss potential reasons for the discrepancy.